GB0517466D0 - Diagnostic assay and therapeutic treatment - Google Patents
Diagnostic assay and therapeutic treatmentInfo
- Publication number
- GB0517466D0 GB0517466D0 GB0517466A GB0517466A GB0517466D0 GB 0517466 D0 GB0517466 D0 GB 0517466D0 GB 0517466 A GB0517466 A GB 0517466A GB 0517466 A GB0517466 A GB 0517466A GB 0517466 D0 GB0517466 D0 GB 0517466D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- diagnostic assay
- therapeutic treatment
- treatment
- mir
- bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
We disclose a diagnostic assay to determine whether a subject has developed, is likely to develop, or is responding to treatment of, a bone disorder, typically osteoporosis, by determining the expression of micro RWA mir-223 or of two gene markers localised with mir-223 on the same gene locus or chromosome X. Pharmaceutical compositions comprising nucleic acids or polypeptides useful in the treatment of said bone disorders are also disclosed.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0517466A GB0517466D0 (en) | 2005-08-26 | 2005-08-26 | Diagnostic assay and therapeutic treatment |
PCT/GB2006/003204 WO2007023306A1 (en) | 2005-08-26 | 2006-08-25 | Diagnostic assay and therapeutic treatment for bone disorders (osteoporosis) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0517466A GB0517466D0 (en) | 2005-08-26 | 2005-08-26 | Diagnostic assay and therapeutic treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0517466D0 true GB0517466D0 (en) | 2005-10-05 |
Family
ID=35198445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0517466A Ceased GB0517466D0 (en) | 2005-08-26 | 2005-08-26 | Diagnostic assay and therapeutic treatment |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0517466D0 (en) |
WO (1) | WO2007023306A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2288126B2 (en) * | 2006-06-01 | 2009-07-06 | Universitat De Les Illes Balears | USE OF FITATE AS AN INHIBITING AGENT FOR THE DISSOLUTION OF CRYSTALS OF SALES CALCICAS FOR THE PREVENTION OR TREATMENT OF OSTEOPOROSIS. |
JP6841661B2 (en) * | 2014-06-13 | 2021-03-10 | ウニヴェルズィテート・フューア・ボーデンクルトゥーア・ウィーン | Compositions and Methods for Diagnosis and Treatment of Fractures and Bone Disorders |
WO2017098052A1 (en) * | 2015-12-10 | 2017-06-15 | Universität Für Bodenkultur Wien | Compositions and methods for the diagnosis and treatment of bone fractures and disorders |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999007891A1 (en) * | 1997-08-05 | 1999-02-18 | Human Genome Sciences, Inc. | 90 human secreted proteins |
AUPP547398A0 (en) * | 1998-08-26 | 1998-09-17 | Medvet Science Pty. Ltd. | Predictive assessment of certain skeletal disorders |
DE10127572A1 (en) * | 2001-05-30 | 2002-12-05 | Pathoarray Gmbh | Tools for the diagnosis, molecular definition and therapy development of chronic inflammatory joint diseases |
EP1419265A2 (en) * | 2001-08-03 | 2004-05-19 | Gene Logic, Inc. | Gene associated with bone disorders |
EP1556490A4 (en) * | 2002-10-22 | 2006-04-05 | Nuvelo Inc | Novel nucleic acids and polypeptides |
WO2005047505A2 (en) * | 2003-08-07 | 2005-05-26 | Whitehead Institute For Biomedical Research | Methods and products for expression of micro rnas |
EP2295604B1 (en) * | 2004-02-09 | 2015-04-08 | Thomas Jefferson University | Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features |
-
2005
- 2005-08-26 GB GB0517466A patent/GB0517466D0/en not_active Ceased
-
2006
- 2006-08-25 WO PCT/GB2006/003204 patent/WO2007023306A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007023306A1 (en) | 2007-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0507960A (en) | therapeutic methods employing nitric oxide precursors | |
WO2004066941A3 (en) | Expression profiles for colon cancer and methods of use | |
WO2008151803A3 (en) | New polymorphisms in abcb1 associated with a lack of clinical response to medicaments | |
WO2007058968A3 (en) | Gene expression profiles and methods of use | |
WO2005100998A3 (en) | Membrane markers for use in cancer diagnosis and therapy | |
WO2009059318A3 (en) | Genes and polymorphisms associated with amd | |
EP2438962A3 (en) | Polynucleotides and polypeptide sequences involved in the process of bone remodeling | |
WO2005067391A3 (en) | Diagnostic test for parkinson's disease | |
WO2009137660A3 (en) | Enhancement of drug therapy by mirna | |
WO2007133682A3 (en) | 100% sequence identity detection methods for variable genomes | |
ATE526975T1 (en) | PKR ACTIVATION USING HYBRIDIZATION CHAIN REACTION | |
WO2008146309A3 (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
BRPI0819193A2 (en) | use of modified base oligonucleotides in nucleic acid hybridization. | |
WO2005032495A8 (en) | Gene expression profiles and methods of use | |
WO2008093165A3 (en) | The use of pgil ohgosaccharyltransferase for o-glycosylating proteins | |
WO2010011283A3 (en) | Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases | |
BRPI0520067A2 (en) | development of a real time pcr assay for pneumococcal DNA detection and diagnosis of pneumococcal disease | |
WO2008088860A3 (en) | Polymorphisms in the egfr pathway as markers for cancer treatment | |
BRPI0816047A2 (en) | oligonucleotide array for detection of a target nucleic acid, methods for detecting the presence or absence of a target nucleic acid and at least two target nucleic acids, kit, reaction mixture and fluorescence-identified amplicon | |
WO2007109733A3 (en) | Diagnostic and prognostic markers and treatment strategies for multiple sclerosis | |
WO2012056451A3 (en) | Peripheral blood gene markers for early diagnosis of parkinson's disease | |
GB0517466D0 (en) | Diagnostic assay and therapeutic treatment | |
WO2006122971A3 (en) | Treatment of disease using an improved regulated expression system | |
MXPA05006034A (en) | Replication protein. | |
MX2016012718A (en) | Determination of single nucleotide polymorphisms useful to predict response for rasagiline. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |